Publications by authors named "Kaoru Takebuchi"
J Infect Chemother
June 2024
Article Synopsis
- - Tecovirimat's role in treating mpox is still not well-understood, prompting a study in Japan to assess its effectiveness and safety across various patient demographics from June 2022 to April 2023.
- - In the study, 19 male patients (average age 38.5 years), primarily with severe disease and many HIV positive, were treated with tecovirimat; results showed that 60% had negative virus tests in their skin lesions within two weeks, with no severe side effects reported.
- - The findings suggest that starting tecovirimat treatment early can likely shorten the time the virus is detectable, especially in HIV-infected patients, who tend to shed the virus longer, raising the risk of transmission
